Difference between revisions of "Coronavirus studies"
(remove extraneous period, template) |
(A compilation of coronavirus studies demonstrates the effectiveness of early treatment by hydroxychloroquine.) |
||
| Line 4: | Line 4: | ||
Here is a sampling of the growing list of valid studies confirming the effectiveness of hydroxychloroquine against COVID-19: | Here is a sampling of the growing list of valid studies confirming the effectiveness of hydroxychloroquine against COVID-19: | ||
| + | == Compilation == | ||
| + | |||
| + | A compilation of coronavirus studies demonstrates the effectiveness of early treatment by hydroxychloroquine.<ref>https://www.researchgate.net/publication/344103059_Hydroxychloroquine_is_Effective_and_Safe_for_the_Treatment_of_COVID-19_and_May_be_Universally_Effective_When_Used_Early_Before_Hospitalization_A_Systematic_Review</ref> | ||
== Minnesota data mining study == | == Minnesota data mining study == | ||
Revision as of 01:04, September 9, 2020
Numerous coronavirus studies demonstrate the prophylactic and early use of hydroxychloroquine against COVID-19, which are being ignored or downplayed for political reasons.
Here is a sampling of the growing list of valid studies confirming the effectiveness of hydroxychloroquine against COVID-19:
Compilation
A compilation of coronavirus studies demonstrates the effectiveness of early treatment by hydroxychloroquine.[1]
Minnesota data mining study
The incidence rate and mortality from COVID-19 was found to be lower in patients on chronic hydroxychloroquine therapy, in a large Minnesota healthcare system.
Between April 1, 2019 and March 31, 2020, the database contained 1,271,014 unique patient encounters, including a total of 2945 COVID-19 tests, of which 125 (4.24%) were positive.
Among the tests performed, 124 (4.35%) were positive for COVID-19 while not having taken hydroxychloroquine, while 96 tests were performed in patients with existing hydroxychloroquine prescriptions and only one (1.04%) was positive.
Two COVID-19 patients not on hydroxychloroquine died, while no COVID-19 patients not on hydroxychloroquine died.
Hydroxychloroquine appears to be effective against COVID-19 both as a prophylaxis and as early treatment.[2]
French study
In a study of 3,737 COVID-19 patients, the researchers found that "Treatment with HCQ-AZ was associated with a decreased risk of transfer to ICU or death (Hazard ratio (HR) 0.18 0.11–0.27), decreased risk of hospitalization ≥10 days and shorter duration of viral shedding."[3]
References
- ↑ https://www.researchgate.net/publication/344103059_Hydroxychloroquine_is_Effective_and_Safe_for_the_Treatment_of_COVID-19_and_May_be_Universally_Effective_When_Used_Early_Before_Hospitalization_A_Systematic_Review
- ↑ https://link.springer.com/content/pdf/10.1007/s40267-020-00741-x.pdf
- ↑ https://www.sciencedirect.com/science/article/pii/S1477893920302817